OR51Q1 | Olfactory receptor, family 51, subfamily Q, member 1 (gene/pseudogene) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
PAQR5 | Progestin and adipoQ receptor family member V | Predicted membrane proteins
| | | | | Tissue enhanced |
PAQR6 | Progestin and adipoQ receptor family member VI | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
PAQR7 | Progestin and adipoQ receptor family member VII | Predicted membrane proteins
| | | | | Mixed |
PAQR8 | Progestin and adipoQ receptor family member VIII | Predicted membrane proteins
| | | | | Mixed |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PCNXL2 | Pecanex-like 2 (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
PHTF1 | Putative homeodomain transcription factor 1 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PHTF2 | Putative homeodomain transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PIGQ | Phosphatidylinositol glycan anchor biosynthesis, class Q | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PORCN | Porcupine homolog (Drosophila) | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
RYR1 | Ryanodine receptor 1 (skeletal) | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SCAP | SREBF chaperone | Predicted membrane proteins
| | | | | Expressed in all |
SEC61A2 | Sec61 alpha 2 subunit (S. cerevisiae) | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC10A3 | Solute carrier family 10, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC10A4 | Solute carrier family 10, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A11 | Solute carrier family 22 (organic anion/urate transporter), member 11 | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A23 | Solute carrier family 22, member 23 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC23A3 | Solute carrier family 23, member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC24A1 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC26A8 | Solute carrier family 26 (anion exchanger), member 8 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35A3 | Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35A4 | Solute carrier family 35, member A4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35B2 | Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35B4 | Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4 | Predicted membrane proteins
| | | | | Mixed |
SLC35D2 | Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35E1 | Solute carrier family 35, member E1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F2 | Solute carrier family 35, member F2 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC35F4 | Solute carrier family 35, member F4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC36A1 | Solute carrier family 36 (proton/amino acid symporter), member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC38A2 | Solute carrier family 38, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
SLC38A5 | Solute carrier family 38, member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC39A1 | Solute carrier family 39 (zinc transporter), member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC39A3 | Solute carrier family 39 (zinc transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A3 | Solute carrier family 41, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC43A2 | Solute carrier family 43 (amino acid system L transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |